Debio 0617B demonstrated dose-dependent inhibition of pSTAT3 in STAT3-activated cancer cell lines as well as suppressing cell proliferation in several cancer cell lines and in malignant xenografts derived from patients (111). Here, STAT3 is linked to cancer.